Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

York University

$30,000.00

Control of gene expression by protein phosphorylation

FY 2018-19

Summary
My research program studies the mechanism of signal transduction and the involvement of protein phosphorylation. I am primarily interested in the protein kinase AKT, and the array of substrates that AKT phosphorylates. AKT is important in the cell physiology field because it controls a multitude of responses to a wide array of extracellular stimuli. Recently, we have discovered that AKT phosphorylates a protein called CDCA7, and this disrupts CDCA7 interaction with an important global transcription factor called MYC. This changes the array of MYC-expressed genes with dramatic effects on cell growth, migration, metabolism and apoptosis. Therefore, we hypothesize that CDCA7 is a critical, and as yet unexplored modulator of MYC through the activity of AKT. Specifically,we hypothesize that activation of AKT selectively down-regulates MYC-dependent apoptotic gene expression by reducing the availability of CDCA7 to MYC. The following three Objectives outline our 5-year plan to explore and test this hypothesis.*1. Mechanisms of CDCA7 interaction with MYC on DNA. We will probe the relationship between CDCA7 phosphorylation by AKT, 14-3-3 binding and association with MYC in cells at specific genomic loci. We have performed ChIP analysis, which showed that CDCA7 associates with DNA at MYC-targeted promoters. This investigation will be expanded to include other genes involved in apoptosis and cell cycle control. We will ask if AKT selectively reduces the interaction of CDCA7 with these promoters, and if CDCA7 association increases following PI3K/AKT inhibition. We will use AKT-insensitive CDCA7 mutations to disrupt the involvement of AKT and examine the effect on gene expression.*2. Structure and functional analysis of CDCA7. It is imperative to understand how CDCA7 interacts with MYC to define how it alters MYC activation. We have mapped the binding site on CDCA7 that interacts with MYC. We will perform reciprocal experiments to determine the site of contact on MYC. We have initial data indicating that CDCA7 binds within 274-440 of MYC, and we will further refine this analysis. *3. Contribution of CDCA7 to MYC-dependent phenotype. We will generate cell models that express CDCA7 to study the impact of CDCA7 on pro-apoptotic gene expression, cell division, and transformation. We will continue our analysis of CDCA7-dependent gene expression by qPCR, and specifically if CDCA7 promotes the expression of apoptotic genes. We will test functional mutations of genomic CDCA7 using CRISPR/Cas9 genome editing on cellular phenotype.*Our discoveries involving CDCA7 and MYC are significant and novel, and will lead to a better understanding of the molecular events underlying the cellular response to extracellular stimuli.*
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2015-06320
Name nom
Scheid, Michael
Department département
Biology
Organization id
38
Institution établissement
York University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2015
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Partie
4
Nb partie
5
Application title
Control of gene expression by protein phosphorylation
Keyword
NSERC
Application summary
My research program studies the mechanism of signal transduction and the involvement of protein phosphorylation. I am primarily interested in the protein kinase AKT, and the array of substrates that AKT phosphorylates. AKT is important in the cell physiology field because it controls a multitude of responses to a wide array of extracellular stimuli. Recently, we have discovered that AKT phosphorylates a protein called CDCA7, and this disrupts CDCA7 interaction with an important global transcription factor called MYC. This changes the array of MYC-expressed genes with dramatic effects on cell growth, migration, metabolism and apoptosis. Therefore, we hypothesize that CDCA7 is a critical, and as yet unexplored modulator of MYC through the activity of AKT. Specifically,we hypothesize that activation of AKT selectively down-regulates MYC-dependent apoptotic gene expression by reducing the availability of CDCA7 to MYC. The following three Objectives outline our 5-year plan to explore and test this hypothesis.*1. Mechanisms of CDCA7 interaction with MYC on DNA. We will probe the relationship between CDCA7 phosphorylation by AKT, 14-3-3 binding and association with MYC in cells at specific genomic loci. We have performed ChIP analysis, which showed that CDCA7 associates with DNA at MYC-targeted promoters. This investigation will be expanded to include other genes involved in apoptosis and cell cycle control. We will ask if AKT selectively reduces the interaction of CDCA7 with these promoters, and if CDCA7 association increases following PI3K/AKT inhibition. We will use AKT-insensitive CDCA7 mutations to disrupt the involvement of AKT and examine the effect on gene expression.*2. Structure and functional analysis of CDCA7. It is imperative to understand how CDCA7 interacts with MYC to define how it alters MYC activation. We have mapped the binding site on CDCA7 that interacts with MYC. We will perform reciprocal experiments to determine the site of contact on MYC. We have initial data indicating that CDCA7 binds within 274-440 of MYC, and we will further refine this analysis. *3. Contribution of CDCA7 to MYC-dependent phenotype. We will generate cell models that express CDCA7 to study the impact of CDCA7 on pro-apoptotic gene expression, cell division, and transformation. We will continue our analysis of CDCA7-dependent gene expression by qPCR, and specifically if CDCA7 promotes the expression of apoptotic genes. We will test functional mutations of genomic CDCA7 using CRISPR/Cas9 genome editing on cellular phenotype.*Our discoveries involving CDCA7 and MYC are significant and novel, and will lead to a better understanding of the molecular events underlying the cellular response to extracellular stimuli.*